These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 12165973

  • 1. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D.
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [Abstract] [Full Text] [Related]

  • 2. Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis.
    Dejica D, Treichel U, Pár A, Chira O, Meyer zum Büschenfelde KH.
    Z Gastroenterol; 1997 Jan; 35(1):15-21. PubMed ID: 9123953
    [Abstract] [Full Text] [Related]

  • 3. Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis.
    Simpson KJ, Jones AL, Forbes Howie A, Hayes PC.
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):455-60. PubMed ID: 7542148
    [Abstract] [Full Text] [Related]

  • 4. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
    D'Cruz D, Direskeneli H, Khamashta M, Hughes GR.
    J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
    [Abstract] [Full Text] [Related]

  • 5. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
    Nielsen OH, Ciardelli T, Wu Z, Langholz E, Kirman I.
    Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis.
    Arranz O, Ara J, Rodríguez R, Saurina A, Mirapeix E, Darnell A.
    J Nephrol; 2000 Aug; 13(1):59-64. PubMed ID: 10720216
    [Abstract] [Full Text] [Related]

  • 7. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.
    Raziuddin S, al-Janadi MA, al-Wabel AA.
    J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190
    [Abstract] [Full Text] [Related]

  • 8. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
    Tang Z, Zhang J, Zhang S, Li L.
    Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
    [Abstract] [Full Text] [Related]

  • 9. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
    Srivastava MD, Rossi TM, Lebenthal E.
    Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
    [Abstract] [Full Text] [Related]

  • 10. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.
    Schmitt WH, Csernok E, Kobayashi S, Klinkenborg A, Reinhold-Keller E, Gross WL.
    Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572
    [Abstract] [Full Text] [Related]

  • 11. [The clinical significance of the measurement of serum soluble interleukin-2 receptors in various diseases].
    Sugimoto H, Hashimoto N, Suzuki S, Gejyo F.
    Rinsho Byori; 1996 Feb; 44(2):176-82. PubMed ID: 8851203
    [Abstract] [Full Text] [Related]

  • 12. [Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes].
    Horák P, Hermanová Z, Ordeltová M, Faltýnek L, Kusá L, Budíková M, Vavrdová V, Opíchalová D, Ciferská H, Scudla V.
    Vnitr Lek; 2004 Jun; 50(6):422-7. PubMed ID: 15346634
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B.
    Rocz Akad Med Bialymst; 2004 Jun; 49():246-51. PubMed ID: 15631351
    [Abstract] [Full Text] [Related]

  • 14. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
    Grüngreiff K, Reinhold D, Ansorge S.
    Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
    Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K.
    Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
    [Abstract] [Full Text] [Related]

  • 16. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
    Nassonov EL, Samsonov MY, Tilz GP, Beketova TV, Semenkova EN, Baranov A, Wachter H, Fuchs D.
    J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
    [Abstract] [Full Text] [Related]

  • 17. Serum cytokine profiles in patients with adult onset Still's disease.
    Choi JH, Suh CH, Lee YM, Suh YJ, Lee SK, Kim SS, Nahm DH, Park HS.
    J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
    [Abstract] [Full Text] [Related]

  • 18. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M, Iravani M, Babaee GR, Ghavamzadeh A.
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [Abstract] [Full Text] [Related]

  • 19. [Changes in interleukin-2 receptor levels in active and inactive pulmonary sarcoidosis].
    Strausz J, Joachim MQ, Rudolf F.
    Orv Hetil; 1991 Aug 18; 132(33):1803-6. PubMed ID: 1870863
    [Abstract] [Full Text] [Related]

  • 20. The relationship between soluble interleukin 2 receptor levels and antidouble stranded DNA antibody levels in patients with systemic lupus erythematosus.
    Ward MM, Dooley MA, Christenson VD, Pisetsky DS.
    J Rheumatol; 1991 Feb 18; 18(2):235-40. PubMed ID: 2023217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.